Timber Hill’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Timber Hill's BIIB Position: Q2 2018 in Review
Timber Hill sold out of Biogen (BIIB) in Q2 2018, closing a stake of 4,910 shares — an estimated $1.34M sold.
Timber Hill first reported a position in BIIB in Q3 2013 and held it in 10 quarters. The position peaked at $8.47M in Q3 2013. 1,097 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.
- Timber Hill reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
- Timber Hill sold 4,910 Biogen shares in Q2 2018, an estimated $1.34M.
- Timber Hill first reported a position in Biogen in Q3 2013 and held it in 10 quarters.
- Timber Hill's Biogen position peaked at $8.47M in Q3 2013.
- 1,097 funds tracked by Wall St. Rank held Biogen as of Q2 2018.
Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.